Though AFP (alpha-fetaprotein) and ultrasonography are widely used for HCC screening in high-risk populations, AFP is not sufficient to distinguish HCC from LC with a sensitivity of 39~65%, a specificity of 76~94%, and a positive predictive value of 9~50%4. This evidence concerns the gene AFP and hepatocellular carcinoma.